Alice Zhang sees a way of tapping machine learning to accelerate the development of new drugs to treat Parkinson's disease and other brain diseases — and dismiss the ones that won't work.

Alice Zhang sees a way of tapping machine learning to accelerate the development of new drugs to treat Parkinson's disease and other brain diseases — and dismiss the ones that won't work.

Alice Zhang sees a way of tapping machine learning to accelerate the development of new drugs to treat Parkinson's disease and other brain diseases —&nbsp;and dismiss the ones that won't work.

How a startup is using machine learning to speed new Parkinson's, ALS drugs

BioFlash is a biweekly podcast, hosted by San Francisco Business Times biotech reporter Ron Leuty. From cancer immunotherapy to drug pricing, we explore the hot topics driving the life sciences ecosystem in the San Francisco Bay Area and beyond.

Share How a startup is using machine learning to speed new Parkinson's, ALS drugs

Sign up to save your podcasts

How a startup is using machine learning to speed new Parkinson's, ALS drugs

How a startup is using machine learning to speed new Parkinson's, ALS drugs